Results 321 to 330 of about 172,684 (356)

Chronic graft-versus-host disease

Current Opinion in Hematology, 1998
Chronic graft-versus-host disease (GVHD) continues to be the major problem in the long-term survivors of allogeneic hematopoietic stem cell transplants. Because of its similarities to autoimmune disease, the pathogenesis of chronic GVHD has been thought to differ from acute GVHD.
openaire   +2 more sources

Predicting graft-versus-host disease

Current Opinion in Immunology, 1995
Graft-versus-host disease (GVHD) is a serious complication that occurs after allogeneic bone marrow transplantation and contributes to transplant-related morbidity and mortality. Recent advances in the measurement of recipient-specific alloreactivity before marrow grafting have led to the development of in vitro assays that sufficiently predict the ...
openaire   +2 more sources

Oral Graft-Versus-Host Disease

Dental Clinics of North America, 2014
Allogeneic hematopoietic cell transplantation (allo-HCT) is used for the treatment of a variety of disorders, primarily hematologic malignancies. Graft-versus-host disease (GVHD) is a significant complication following allo-HCT and a major cause of morbidity and mortality.
Michal, Kuten-Shorrer, Sook-Bin, Woo, Nathaniel S, Treister   +2 more
openaire   +2 more sources

Acute graft-versus-host disease

1990
Acute graft-versus-host disease (GVHD) occurs after allogeneic hematopoietic stem cell transplant and is a reaction of donor immune cells against host tissues. Activated donor T cells damage host epithelial cells after an inflammatory cascade that begins with the preparative regimen.
openaire   +2 more sources

Graft-versus-Host Disease

New England Journal of Medicine, 1979
E D, Thomas, A, Fefer
openaire   +2 more sources

Graft-Versus-Host Disease: Implications

1993
The intent of the preparative regimen for bone marrow transplantation (BMT) is the destruction of the host tumor cell and the complete ablation of the host lymphohematopoietic system (Thomas 1983). Most aggressive conditioning regimens are applied, usually combining chemo- and radiotherapy, the latter in the form of total body irradiation.
openaire   +2 more sources

Esophageal graft versus host disease

Indian Journal of Gastroenterology, 2021
Zohaib A. W. Khan, Shiraz S. Khan, Saad Al-Kaabi, Adham A. Ammar   +3 more
openaire   +2 more sources

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Ca-A Cancer Journal for Clinicians, 2021
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel   +2 more
exaly  

Breast Cancer Statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Hyuna Sung, Kimberly D Miller, Rebecca L Siegel   +2 more
exaly  

Radiotheranostics in oncology: Making precision medicine possible

Ca-A Cancer Journal for Clinicians, 2023
Eric Aboagye
exaly